AGILERA PHARMA AS

Signals

1 flags

• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−29,0 mill kr).

AGILERA PHARMA AS is registered as a limited company in Lillestrøm, Akershus with organisation number 928041069. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2021 and has 137 registered employees. Registered share capital is NOK 4.5m, divided into 30000 shares. The company's stated purpose is: “Drive forskning, utvikling og produksjon av nye løsninger for medisin ved bruk av radioaktive kilder, samt andre aktiviteter som står i forbindelse hermed, herunder samarbeid med, deltakelse og eierskap i andre selskaper.”. The most recent filed accounts, for the 2024 financial year, show NOK 357.6m in revenue and NOK −29.0m in operating profit.

Key figures · 2024

Revenue

NOK 357.6m

Operating profit

NOK −29.0m

Equity

NOK 15.0m

Est. value

NOK 181.2m

Financial health · 2024

Liquidity

1.13

Satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

10.1%

Satisfactory

Equity as a share of total capital

Who owns AGILERA PHARMA AS?

PHARMALOGIC NORWAY AS

51.0%

AGILERA PHARMA AS

NOK 357.6m rev. · NOK −29.0m profit

AGILERA PHARMA AS has 2 registered shareholders:

• PHARMALOGIC NORWAY AS 51.0%
• IFE HOLDING AS 49.0%

All shareholders and roles →

Frequently asked questions about AGILERA PHARMA AS

Who owns AGILERA PHARMA AS?

PHARMALOGIC NORWAY AS is the largest registered owner, with 51.0%.

What is the revenue of AGILERA PHARMA AS?

AGILERA PHARMA AS had revenue of NOK 357.6m in 2024.

Who is the general manager of AGILERA PHARMA AS?

Erik Flatmark is registered as general manager of AGILERA PHARMA AS.

Where is AGILERA PHARMA AS based?

AGILERA PHARMA AS has its business address in Kjeller.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.